Skip to main content
Sunil Krishnan, MD, Radiation Oncology, Houston, TX

Sunil Krishnan MD


Physician

Join to View Full Profile
  • 6400 Fannin St Ste 220Houston, TX 77030

  • Phone+1 713-704-2650

  • Fax+1 713-704-5710

Dr. Krishnan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 2000 - 2004
  • Geisinger Health System (Danville)
    Geisinger Health System (Danville)Residency, Internal Medicine, 1997 - 2000
  • Christian Medical College Vellore
    Christian Medical College VelloreClass of 1995

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2004 - 2027
  • FL State Medical License
    FL State Medical License 2019 - 2024
  • MN State Medical License
    MN State Medical License 2000 - 2004
  • PA State Medical License
    PA State Medical License 1997 - 2000
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Mayo Clinic Research in the News — 4/12/2021
    Mayo Clinic Research in the News — 4/12/2021April 12th, 2021
  • Looking Back on 2020: A Successful Year of Research at Mayo Clinic in Florida
    Looking Back on 2020: A Successful Year of Research at Mayo Clinic in FloridaJanuary 5th, 2021
  • Competitive Alligators Chomp at the Bit to Showcase Health Care Innovations
    Competitive Alligators Chomp at the Bit to Showcase Health Care InnovationsDecember 15th, 2020
  • Join now to see all

Grant Support

  • In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
  • In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
  • In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
  • Rational translation of gold nanoparticle mediated radiosensitization to the clinicUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2021–2026
  • Rational translation of gold nanoparticle mediated radiosensitization to the clinicUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2021–2026
  • Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticlesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: